Image

Vibration Therapy and IASTM in Subacromial Impingement Syndrome

Vibration Therapy and IASTM in Subacromial Impingement Syndrome

Recruiting
40-60 years
All
Phase N/A

Powered by AI

Overview

This randomized controlled clinical study aims to investigate the effects of vibration therapy and instrument-assisted soft tissue mobilization (IASTM), when added to conventional physiotherapy, on pain, range of motion, proprioception, functional status, and quality of life in individuals diagnosed with subacromial impingement syndrome (SAIS). SAIS is one of the most common causes of shoulder pain and is frequently associated with impaired scapular kinematics, rotator cuff dysfunction, soft tissue tightness, and decreased shoulder mobility.

A total of 48 participants aged 40-60 years with MRI-confirmed SAIS will be randomly assigned into three groups: (1) Vibration Therapy + Conventional Physiotherapy, (2) IASTM + Conventional Physiotherapy, and (3) Conventional Physiotherapy (Control). All interventions will be administered three times per week for four weeks. Outcomes include pain intensity (VAS), shoulder range of motion (Goniometer Pro app), proprioception at 60° of flexion and abduction, functional status (DASH), and quality of life (RC-QoL).

The study aims to determine whether adding vibration therapy or IASTM to standard physiotherapy provides additional short-term benefits in reducing pain, improving joint mobility, enhancing proprioceptive acuity, and increasing functional capacity in individuals with subacromial impingement syndrome.

Description

Subacromial impingement syndrome (SAIS) is one of the most frequently encountered musculoskeletal disorders, affecting approximately 20-30% of the general population and representing a major cause of shoulder pain. SAIS has been associated with altered scapular kinematics, rotator cuff muscle imbalance, soft-tissue tightness, postural abnormalities, and impaired neuromuscular control. Conventional physiotherapy-including therapeutic exercises, stretching, electrotherapy modalities, and manual techniques-is commonly used in clinical practice. However, evidence suggests that combining manual or soft-tissue-based interventions with standard physiotherapy may yield more effective improvements in pain, mobility, and shoulder function.

Instrument-assisted soft tissue mobilization (IASTM) is a manual therapy technique that uses ergonomically designed stainless steel tools to provide controlled mechanical stimulation to soft tissues. IASTM has recently gained attention due to its ability to increase soft-tissue extensibility, promote myofascial release, and enhance joint range of motion. Similarly, vibration-based interventions-including percussion massage therapy-have been shown to improve circulation, decrease pain, reduce muscle stiffness, and enhance mobility through mechanical oscillation and stimulation of sensory receptors. Despite their growing popularity, limited evidence exists regarding the direct comparison of vibration therapy and IASTM in individuals with SAIS.

This randomized controlled trial aims to evaluate whether adding vibration therapy or IASTM to conventional physiotherapy provides superior outcomes compared with conventional physiotherapy alone. A total of 48 adults aged 40-60 years with MRI-confirmed SAIS will be randomly allocated into three groups: (1) Vibration Therapy + Conventional Physiotherapy, (2) IASTM + Conventional Physiotherapy, and (3) Conventional Physiotherapy (Control). All interventions will be delivered three times per week for four weeks. Vibration therapy will be applied using a percussion massage device (33 Hz) to the deltoid and rotator cuff muscles along the origin-to-insertion path. IASTM will be applied using standardized sweep and brush techniques at a 45° angle to both anterior and posterior shoulder muscle groups. The control group will receive conventional physiotherapy consisting of ultrasound, TENS, cryotherapy, passive stretching, Codman exercises, wand exercises, finger ladder exercises, and progressive strengthening, supervised by a physiotherapist.

Outcome measures include pain intensity (VAS), shoulder range of motion measured with the Goniometer Pro mobile application, proprioception assessed at 60° flexion and abduction, functional disability evaluated using the DASH questionnaire, and shoulder-related quality of life measured with the RC-QoL scale. Assessments will be conducted at baseline and after the 4-week intervention period.

This study seeks to contribute to the current literature by directly comparing two frequently used soft-tissue interventions-vibration therapy and IASTM-within the SAIS population. The findings are expected to inform clinicians about the potential added benefits of combining these modalities with conventional physiotherapy to optimize pain reduction, functional improvement, and neuromuscular outcomes in individuals with subacromial impingement syndrome.

Eligibility

Inclusion Criteria:

  • Individuals diagnosed with subacromial impingement syndrome confirmed by MRI
  • Men and women between 40 and 60 years of age
  • Presence of symptoms for more than one month

Exclusion Criteria:

  • History of surgery on the affected arm
  • Presence of an open wound on the arm
  • Existing infection
  • Inflammatory joint disease
  • Shoulder osteoarthritis
  • Presence of rheumatic disease
  • Malignant or benign tumors
  • Inability to tolerate vibration therapy

Study details
    Impingement Syndrome
    Impingement Shoulder
    Shoulder Pain

NCT07291843

Emre DANSUK

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.